Silence Therapeutics: Funding, Investors & Team (Oct 2026)
Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types.
Silence Therapeutics has raised $20.0M across 1 funding round on record, the most recent a Post-IPO Equity of $20.0M announced in Nov 2021.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Silence Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Silence Therapeutics Funding Rounds
Silence Therapeutics Founders and Leadership Team
Contact details for the Silence Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Silence Therapeutics Funding Compared to Other Biotechnology Startups
Silence Therapeutics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Silence Therapeutics in Biotechnology and London
Companies Similar to Silence Therapeutics
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Silence Therapeutics Funding FAQs
What does Silence Therapeutics do?
Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types.
How much funding has Silence Therapeutics raised?
Silence Therapeutics has raised $20.0M across 1 round on record. The most recent is a Post-IPO Equity of $20.0M announced in Nov 2021.
When did Silence Therapeutics last raise funding?
Silence Therapeutics' most recent funding round on record is a Post-IPO Equity of $20.0M, announced in Nov 2021.
Who is the CEO of Silence Therapeutics?
Mark Rothera is listed as CEO at Silence Therapeutics.
Where is Silence Therapeutics headquartered?
Silence Therapeutics is based in London, England, United Kingdom.
How many employees does Silence Therapeutics have?
Silence Therapeutics is in the 101-250 employee band.
How does Silence Therapeutics' funding compare to other Biotechnology startups?
Silence Therapeutics' latest round of $20.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Silence Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Silence Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.